Quarterly report pursuant to Section 13 or 15(d)

Note 7 - Stockholders' Deficit

v3.8.0.1
Note 7 - Stockholders' Deficit
9 Months Ended
Sep. 30, 2017
Notes  
Note 7 - Stockholders' Deficit

NOTE 7 - STOCKHOLDERS’ DEFICIT

 

Board of Directors fees

 

As compensation for serving as a member of the board of directors, the Company granted warrants to purchase 125,000 shares of common stock to Robert O. Rondeau, a new Director, in March 2016, at an exercise price of $.09 per share. The warrants have a term of five years and vested immediately. The warrants were valued at $10,588 using the Black Scholes pricing model relying on the following assumptions: volatility 168.01%; annual rate of dividends 0%; discount rate 0.97%. In addition, Mr. Rondeau will receive $10,000 for each annual term served, paid quarterly.

 

On September 10, 2016, the board of directors granted to each of its Directors warrants to purchase 250,000 shares of common stock at an exercise price of $.05 per share. The warrants have a term of five years and vest immediately. The warrants were valued at $59,125 using the Black Scholes pricing model relying on the following assumptions: volatility 171.58%; annual rate of dividends 0%; discount rate 0.79%. In addition, each director is entitled to receive $10,000 for each annual term served.

 

On September 11, 2017, the board of directors granted to each of its Directors warrants to purchase 500,000 shares of common stock at an exercise price of $.07 per share. The warrants have a term of five years and vest immediately. The warrants were valued at $166,668 using the Black Scholes pricing model relying on the following assumptions: volatility 175.54%; annual rate of dividends 0%; discount rate 1.71%. In addition, each director is entitled to receive $10,000 for each annual term served.

 

The Company recorded directors’ fees of $196,668 and $99,713 for the nine months ended September 30, 2017 and 2016, respectively, representing the cash fees and the value of the vested warrants described above.

 

Stock Based Compensation

 

During the nine months ended September 30, 2016, the Company issued warrants to purchase 14,500,000 shares of common stock at an exercise price of $.08 with a term of 5 years pursuant to agreements with financial consultants. The warrants were valued at $1,095,063 using the Black Scholes pricing model relying on the following assumptions: volatility 170.07%; annual rate of dividends 0%; discount rate 0.89%. The Company also issued 3,500,000 shares of common stock, valued at $175,000, to an investor relations consulting firm.

 

On April 18, 2017, the Company entered into a Limited License Agreement (“License Agreement”) with NutriQuest, LLC ("NutriQuest"), as disclosed in a Form 8-K filed on April 26, 2017. Pursuant to the agreement, the Company issued NutriQuest warrants to purchase 687,227 shares of common stock valued at $45,662 using the Black Scholes pricing model relying on the following assumptions: volatility 175.75%; annual rate of dividends 0%; discount rate 1.78%. The warrants are exercisable at $.08 per share and expire five (5) years from the date of issuance. The License Agreement provides that the Company is obligated to pay a termination fee to NutriQuest if the parties are unable to agree upon quality and volume delivered standards.

 

During the nine months ended September 30, 2017, the Company issued warrants to purchase 17,000,000 shares of common stock. In the first quarter, the Company issued warrants to purchase 500,000 shares of common stock at an exercise price of $.10 with a term of 5 years pursuant to an agreement as a financial consultant. The warrants were valued at $33,148 using the Black Scholes pricing model relying on the following assumptions: volatility 175.05%; annual rate of dividends 0%; discount rate 1.87%. In the third quarter, the Company issued warrants to purchase 16,250,000 shares of common stock at an exercise price of $.06 to $.07 with a term of 5 years pursuant to agreements with financial consultants. The warrants were valued at $923,430 using the Black Scholes pricing model relying on the following assumptions: volatility 175.61% to 175.58%; annual rate of dividends 0%; discount rate 1.63% to 1.79%. Also, in the third quarter, the Company issued warrants to purchase 250,000 shares of common stock at an at an exercise price of $.07 with a term of 5 years pursuant to an agreement with a research consultant. The warrants were valued at $16,667 using the Black Scholes pricing model relying on the following assumptions: volatility 175.61%; annual rate of dividends 0%; discount rate 1.63%.

 

Stock Issuances

 

During the nine months ended September 30, 2016, in connection with the issuance of $2,350,000 in principal of 11% Convertible Debenture the Company issued 960,000 shares of common stock valued at $63,000 and warrants to purchase 2,712,500 shares of common stock at an exercise price of $.10 per share as financing costs related to the issuance of the 11% convertible debt. The warrants were valued at $113,231 using the Black Scholes pricing model relying on the following assumptions: volatility 158.5% to 172.8%; annual rate of dividends 0%; discount rate 0.75% to 0.85%.

 

During the nine months ended September 30, 2017, in connection with the issuance of $3,500,000 in principal of 11% Convertible Debenture the Company issued to HEP Investments 1,735,714 shares of common stock valued at $126,000 and a five-year warrant to purchase 3,500,000 shares of common stock at an exercise price of $.10 per share. The Company also issued 250,000 shares of common stock valued at $22,500 as discussed in Note 10 - Settlement of Litigation – Related Party.

 

Executive Compensation

 

As compensation for serving as Chief Financial Officer, the Company, quarterly, issues warrants to purchase 50,000 shares of common stock to Philip M. Rice at the prevailing market price with a term of 5 years, provided that the preceding quarterly and annual filings were submitted in a timely and compliant manner, at which time such warrants would vest.

 

On March 29, 2016, the Company issued warrants to purchase 50,000 shares of common stock at $.08. The warrants were valued at $3,771 using the Black Scholes pricing model relying on the following assumptions: volatility 169.28%; annual rate of dividends 0%; discount rate 0.78%. On May 13, 2016, the Company issued warrants to purchase 50,000 shares of common stock at $.08. The warrants were valued at $3,777 using the Black Scholes pricing model relying on the following assumptions: volatility 170.23%; annual rate of dividends 0%; discount rate 0.76%. On August 12, 2016, the Company issued warrants to purchase 50,000 shares of common stock at $.07. The warrants were valued at $3,307 using the Black Scholes pricing model relying on the following assumptions: volatility 170.83%; annual rate of dividends 0%; discount rate 0.71%.

 

On March 31, 2017, the Company issued warrants to purchase 50,000 shares of common stock at $.08. The warrants were valued at $3,317 using the Black Scholes pricing model relying on the following assumptions: volatility 175.53%; annual rate of dividends 0%; discount rate 1.93%. On May 12, 2017, the Company issued warrants to purchase 50,000 shares of common stock at $.09. The warrants were valued at $4,283 using the Black Scholes pricing model relying on the following assumptions: volatility 176.74%; annual rate of dividends 0%; discount rate 1.93%. On August 11, 2017, the Company issued warrants to purchase 50,000 shares of common stock at $.06. The warrants were valued at $2,363 using the Black Scholes pricing model relying on the following assumptions: volatility 177.01%; annual rate of dividends 0%; discount rate 1.74%.

 

Common Stock Warrants

 

A summary of the status of the Company’s warrants is presented below.

 

 

 

September 30, 2017

 

December 31, 2016

 

Number of

Warrants

 

Weighted

Average

Exercise

Price

 

Number of

Warrants

 

Weighted

Average

Exercise

Price

 

 

 

 

 

 

 

 

Outstanding, beginning of year

32,071,901

$

0.13

 

14,705,818

$

0.16

Issued

21,587,227

 

0.07

 

20,350,000

 

0.09

Exercised

-

 

-

 

-

 

-

Cancelled

-

 

-

 

-

 

-

Expired

(1,507,374)

 

0.17

 

(2,983,917)

 

0.13

Outstanding, end of period

52,151,754

$

0.08

 

32,071,901

$

0.13

 

Warrants outstanding and exercisable by price range as of September 30, 2017 were as follows:

 

 

 

Outstanding Warrants

 

 

Exercisable Warrants

 

 

 

 

 

Average

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

Remaining

 

 

 

 

 

 

 

Exercise

Price

 

Number

 

Contractual

Life in Years

 

 

Exercise

Price

 

Number

 

Weighted

Average

Exercise

Price

 

 

 

 

 

 

 

 

 

 

 

 

 

$

0.05

 

1,250,000

 

3.95

 

$

0.05

 

1,250,000

$

0.05

 

0.06

 

 16,050,000

 

4.87

 

 

0.06

 

16,050,000

 

0.06

 

0.07

 

3,000,000

 

4.95

 

 

0.07

 

3,000,000

 

0.07

 

0.08

 

18,612,227

 

3.50

 

 

0.08

 

18,612,227

 

0.08

 

0.09

 

759,110

 

4.78

 

 

0.09

 

759,110

 

0.09

 

0.10

 

9,427,200

 

3.55

 

 

0.10

 

9,427,200

 

0.10

 

0.12

 

50,000

 

2.87

 

 

0.12

 

50,000

 

0.12

 

0.14

 

50,000

 

1.87

 

 

0.14

 

50,000

 

0.14

 

0.15

 

1,376,941

 

1.93

 

 

0.15

 

1,376,941

 

0.15

 

0.17

 

50,000

 

1.50

 

 

0.17

 

50,000

 

0.17

 

0.19

 

50,000

 

1.62

 

 

0.19

 

50,000

 

0.19

 

0.22

 

269,276

 

1.00

 

 

0.22

 

269,276

 

0.22

 

0.25

 

707,000

 

0.63

 

 

0.25

 

707,000

 

0.25

 

0.30

 

250,000

 

1.18

 

 

0.30

 

250,000

 

0.30

 

0.33

 

250,000

 

0.75

 

 

0.33

 

250,000

 

0.33

 

 

 

52,151,754

 

3.89

 

 

 

 

52,151,754

$

0.08